Genomictree Inc.
228760
Kedudukan dalam Saham
#19175
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Harga Saham
$6.61
Modal Pasaran
$162.26M
Perubahan (1 hari)
1.06%
Perubahan (1 tahun)
-50.87%
Negara
KR
Perdagangan Genomictree Inc. (228760)
Kategori
Healthcare
Modal pasaran bagi Genomictree Inc.(228760)
Modal Pasaran: $162.26M
Sehingga October 2026, Genomictree Inc. mempunyai modal pasaran sebanyak $162.26M. Ini menjadikan Genomictree Inc. syarikat ke-19175th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Genomictree Inc. dari 2017 hingga 2026
228760 berbanding dengan 5 teratas yang paling popular stocks
